These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 10780912)

  • 41. Alterations in EGF-dependent proliferative and phosphorylation events in squamous cell carcinoma cell lines by a tyrosine kinase inhibitor.
    Brunton VG; Carlin S; Workman P
    Anticancer Drug Des; 1994 Aug; 9(4):311-29. PubMed ID: 7916899
    [TBL] [Abstract][Full Text] [Related]  

  • 42. In vivo pharmacology and anti-tumour evaluation of the tyrphostin tyrosine kinase inhibitor RG13022.
    McLeod HL; Brunton VG; Eckardt N; Lear MJ; Robins DJ; Workman P; Graham MA
    Br J Cancer; 1996 Dec; 74(11):1714-8. PubMed ID: 8956783
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The degree of inhibition of protein tyrosine kinase activity by tyrphostin 23 and 25 is related to their instability.
    Ramdas L; McMurray JS; Budde RJ
    Cancer Res; 1994 Feb; 54(4):867-9. PubMed ID: 7508821
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Tyrphostin AG 1478 preferentially inhibits human glioma cells expressing truncated rather than wild-type epidermal growth factor receptors.
    Han Y; Caday CG; Nanda A; Cavenee WK; Huang HJ
    Cancer Res; 1996 Sep; 56(17):3859-61. PubMed ID: 8752145
    [TBL] [Abstract][Full Text] [Related]  

  • 45. EGF induces tyrosine phosphorylation of phospholipase C-II: a potential mechanism for EGF receptor signaling.
    Margolis B; Rhee SG; Felder S; Mervic M; Lyall R; Levitzki A; Ullrich A; Zilberstein A; Schlessinger J
    Cell; 1989 Jun; 57(7):1101-7. PubMed ID: 2472218
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Tyrosine kinase inhibitors. 17. Irreversible inhibitors of the epidermal growth factor receptor: 4-(phenylamino)quinazoline- and 4-(phenylamino)pyrido[3,2-d]pyrimidine-6-acrylamides bearing additional solubilizing functions.
    Smaill JB; Rewcastle GW; Loo JA; Greis KD; Chan OH; Reyner EL; Lipka E; Showalter HD; Vincent PW; Elliott WL; Denny WA
    J Med Chem; 2000 Apr; 43(7):1380-97. PubMed ID: 10753475
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Synthesis and biological evaluations of 3-substituted indolin-2-ones: a novel class of tyrosine kinase inhibitors that exhibit selectivity toward particular receptor tyrosine kinases.
    Sun L; Tran N; Tang F; App H; Hirth P; McMahon G; Tang C
    J Med Chem; 1998 Jul; 41(14):2588-603. PubMed ID: 9651163
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inhibition of neuropeptide-stimulated tyrosine phosphorylation and tyrosine kinase activity stimulates apoptosis in small cell lung cancer cells.
    Tallett A; Chilvers ER; Hannah S; Dransfield I; Lawson MF; Haslett C; Sethi T
    Cancer Res; 1996 Sep; 56(18):4255-63. PubMed ID: 8797601
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Influence of the linker in bispyridium compounds on the inhibition of human choline kinase.
    Conejo-García A; Báñez-Coronel M; Sánchez-Martín RM; Rodríguez-González A; Ramos A; Ramírez de Molina A; Espinosa A; Gallo MA; Campos JM; Lacal JC
    J Med Chem; 2004 Oct; 47(22):5433-40. PubMed ID: 15481981
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Synthesis and antiproliferative activity of tyrphostins containing quinoline moieties.
    Brunton VG; Lear MJ; McKeown P; Robins DJ; Workman P
    Anticancer Drug Des; 1996 Sep; 11(6):463-83. PubMed ID: 8836111
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Thiazolidine-diones. Biochemical and biological activity of a novel class of tyrosine protein kinase inhibitors.
    Geissler JF; Traxler P; Regenass U; Murray BJ; Roesel JL; Meyer T; McGlynn E; Storni A; Lydon NB
    J Biol Chem; 1990 Dec; 265(36):22255-61. PubMed ID: 2176210
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Inhibition of calcineurin by the tyrphostin class of tyrosine kinase inhibitors.
    Martin BL
    Biochem Pharmacol; 1998 Aug; 56(4):483-8. PubMed ID: 9763224
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Tyrphostins. 3. Structure-activity relationship studies of alpha-substituted benzylidenemalononitrile 5-S-aryltyrphostins.
    Gazit A; Osherov N; Posner I; Bar-Sinai A; Gilon C; Levitzki A
    J Med Chem; 1993 Nov; 36(23):3556-64. PubMed ID: 7902440
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Quinazoline-tyrphostin as a new class of antitumor agents, molecular properties prediction, synthesis and biological testing.
    Alafeefy AM; Alqasoumi SI; Ashour AE; Masand V; Al-Jaber NA; Ben Hadda T; Mohamed MA
    Eur J Med Chem; 2012 Jul; 53():133-40. PubMed ID: 22520152
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Structural studies on bioactive compounds. 23. Synthesis of polyhydroxylated 2-phenylbenzothiazoles and a comparison of their cytotoxicities and pharmacological properties with genistein and quercetin.
    Stevens MF; McCall CJ; Lelieveld P; Alexander P; Richter A; Davies DE
    J Med Chem; 1994 May; 37(11):1689-95. PubMed ID: 8201603
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Tyrosine kinase activity is necessary for growth factor-stimulated rabbit type II pneumocyte proliferation.
    Chess PR; Ryan RM; Finkelstein JN
    Pediatr Res; 1994 Oct; 36(4):481-6. PubMed ID: 7529394
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Inhibition of epidermal growth factor receptor-associated tyrosine kinase blocks glioblastoma invasion of the brain.
    Penar PL; Khoshyomn S; Bhushan A; Tritton TR
    Neurosurgery; 1997 Jan; 40(1):141-51. PubMed ID: 8971836
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inhibitors of tyrosine kinases in the treatment of psoriasis.
    Ben-Bassat H; Klein BY
    Curr Pharm Des; 2000 Jun; 6(9):933-42. PubMed ID: 10828317
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The anti-proliferative effect of suramin towards tamoxifen-sensitive and resistant human breast cancer cell lines in relation to expression of receptors for epidermal growth factor and insulin-like growth factor-I: growth stimulation in the presence of tamoxifen.
    Boylan M; van den Berg HW; Lynch M
    Ann Oncol; 1998 Feb; 9(2):205-11. PubMed ID: 9553667
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tyrosine kinase inhibitors. 9. Synthesis and evaluation of fused tricyclic quinazoline analogues as ATP site inhibitors of the tyrosine kinase activity of the epidermal growth factor receptor.
    Rewcastle GW; Palmer BD; Bridges AJ; Showalter HD; Sun L; Nelson J; McMichael A; Kraker AJ; Fry DW; Denny WA
    J Med Chem; 1996 Feb; 39(4):918-28. PubMed ID: 8632415
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.